|
|||||
|
|
Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype |
|
| Authors: | Jiayin Deng,Ai-Ling Tian,Hui Pan,Allan Sauvat,Marion Leduc,Peng Liu,Liwei Zhao,Shuai Zhang,Hui Chen,Valé rie Taly,Pierre Laurent-Puig,Laura Senovilla,Yingqiu Li,Guido Kroemer,Oliver Kepp |
| Abstract: | |
| Keywords: | |